Pakistan’s pharmaceutical industry claims that around 40 medical companies will be forced to close due to unaffordable production costs caused by the rupee’s devaluation, import hiccups and spiraling inflation.
Pakistan’s pharmaceutical industry claims that around 40 medical companies will be forced to close due to unaffordable production costs caused by the rupee’s devaluation, import hiccups and spiraling inflation.